Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. A randomized, double-blind, placebo-controlled cross-over study with neuropsychological tests.
In order to examine if the nootropic drug, aniracetam, was capable of improving cognitive performance, 44 subjects suffering from chronic psychosyndrome after long-term exposure to organic solvents were included in a randomized, double-blind, placebo-controlled, cross-over study. The treatment periods were 3 months with aniracetam 1 g daily and 3 months with placebo. Neuropsychological tests as well as a physical and neurological examination were performed at entry into the study and after each treatment period, together with an evaluation of the subjects' overall condition. Neither the doctors' nor the subjects' own assessment of the overall condition indicated that the trial medication had had any effect. No significant changes in neuropsychological symptoms were observed. A statistically significant difference in favour of antiracetam was found in only 1 of the 19 neuropsychological test measures, namely a test for constructional ability. However, in another test on visuo-spatial function, a statistically significant result was found in favour of placebo. Thus, aniracetam was found to be ineffective in the treatment of subjects suffering from chronic psychosyndrome after long-term exposure to organic solvents.
Department of Neurology, Rigshospitalet University Hospital, Copenhagen, Denmark.
F E
FE
Somnier
M S
MS
Ostergaard
G
G
Boysen
P
P
Bruhn
B O
BO
Mikkelsen
D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011581:Psychological Tests; D011605:Psychoses, Substance-Induced / Q000188:drug therapy* / Q000523:psychology; D011760:Pyrrolidinones / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012997:Solvents / Q000633:toxicity*
D011760:Pyrrolidinones; D012997:Solvents; C036466:aniracetam